Clinical Trials

Clinical trials are essential to evaluating the safety and efficacy of new therapies for patients living with immunologic conditions. Availability of data from clinical trials sponsored by UCB provides transparency and fosters advances in patient care. As part of our commitment to patients and the healthcare community at large, UCB shares information about our clinical trials and makes the results of these studies publicly available. The interventions being studied and their uses may be investigational and not approved by the US Food and Drug Administration. Note: Searching by the generic name (e.g., certolizumab pegol) may deliver different results than a search by the code name (e.g., CDP870); therefore, it may be necessary to search by both for complete results.

FILTERS
All Disease States
All Disease States
Ankylosing Spondylitis
Anterior Uveitis
Axial Spondyloarthritis
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Crohn's Disease
Hidradenitis Suppurativa
Immune Thrombocytopenia
Juvenile Idiopathic Arthritis
Myasthenia Gravis
Nonradiographic Axial Spondyloarthritis
Psoriasis
Psoriatic Arthritis
Rheumatoid Arthritis
Sjögren's Syndrome
Sperm Quality
Systemic Lupus Erythematosus
Ulcerative Colitis
Any Status
Any Status
Active, not recruiting
Completed
Not yet recruiting
Recruiting
Suspended
Terminated
Unknown
Withdrawn
All Interventions
All Interventions
Bimekizumab
UCB4940
Certolizumab Pegol
CDP870
Dapirolizumab
CDP7657
Olokizumab
CDP6038
Rozanolixizumab
UCB7665
Seletalisib
UCB5857
Clinical Trials Investigator

Become a UCB Clinical Trial Investigator

If you are interested in being an investigator for a UCB-sponsored clinical trial, please forward your curriculum vitae, including a brief description of your therapeutic area specialty, along with the NCT number of the study you are interested in (if applicable) to:

ucbcares@ucb.com fax: 740-970-8859
ucbCARES®
UCB, Inc.
1950 Lake Park Drive
Smyrna, GA 30080